# AIPL1

## Overview
The AIPL1 gene encodes the aryl hydrocarbon receptor interacting protein-like 1, a specialized chaperone protein predominantly expressed in the retina. This protein is crucial for the proper functioning and maintenance of photoreceptor cells, particularly through its role in stabilizing the phosphodiesterase 6 (PDE6) complex, which is essential for the phototransduction process. AIPL1 contains several structural domains, including an FK506-binding protein (FKBP)-like domain, a tetratricopeptide repeat (TPR) domain, and a proline-rich domain (PRD), which facilitate its interactions with other proteins such as HSP90 and PDE6. These interactions are vital for the correct folding and assembly of PDE6, protecting it from degradation. Mutations in the AIPL1 gene are linked to retinal diseases, most notably Leber congenital amaurosis (LCA), highlighting its clinical significance in vision-related disorders (Yadav2015Extended; SacristanReviriego2020Clinical; Ramamurthy2003AIPL1).

## Structure
The AIPL1 protein is composed of several distinct domains that contribute to its function. It includes an N-terminal FK506-binding protein (FKBP)-like domain, a tetratricopeptide repeat (TPR) domain, and a primate-specific C-terminal proline-rich domain (PRD) (SacristanReviriego2020Clinical). The FKBP-like domain is characterized by a unique 'loop-out' conformation of the β4-α1 loop and a 'flip-out' switch of the W72 residue, which are critical for its prenyl lipid binding capability (Yadav2017Unique). This domain binds isoprenyl groups on PDE6, a function not shared by other FKBP proteins (Yadav2017Unique).

The TPR domain consists of three tetratricopeptide repeats, each composed of a pair of antiparallel helices, and is involved in protein-protein interactions, particularly with HSP90 (SacristanReviriego2020Clinical; Ramamurthy2003AIPL1). The PRD is an extended, unstructured random coil that does not significantly impact the structural properties or thermal stability of AIPL1 (Yadav2015Extended; SacristanReviriego2020Clinical).

AIPL1's structure is crucial for its role in the retina, where it functions as a specialized chaperone for cGMP-specific phosphodiesterase-6 (PDE6), essential in the phototransduction cascade (Yadav2015Extended). The protein's unique structural features support its function and are implicated in retinal diseases such as Leber congenital amaurosis (LCA) (Yadav2017Unique).

## Function
The AIPL1 gene encodes a protein that plays a critical role in the function and maintenance of photoreceptor cells in the retina. AIPL1 is primarily expressed in rod photoreceptors and is essential for the stability and function of the phosphodiesterase 6 (PDE6) complex, which is crucial for phototransduction, the process by which light is converted into electrical signals in the retina (SacristanReviriego2017The; van2002The). AIPL1 acts as a co-chaperone, interacting with heat shock proteins HSP90 and HSP70 to facilitate the correct folding and assembly of PDE6, thereby protecting it from degradation (SacristanReviriego2018The; SacristanReviriego2017The).

AIPL1 is also involved in the processing of farnesylated proteins, which are essential for maintaining retinal cytoarchitecture and photoreceptor structure (Ramamurthy2003AIPL1). The protein contains tetratricopeptide repeat (TPR) motifs and a proline-rich domain, which are involved in protein-protein interactions and may regulate protein folding and stabilization (Akey2002The). Mutations in AIPL1 can lead to misfolding and degradation of the protein, contributing to retinal diseases such as Leber congenital amaurosis (LCA) (Gallon2004Purification).

## Clinical Significance
Mutations in the AIPL1 gene are primarily associated with Leber congenital amaurosis (LCA), a severe form of inherited retinopathy that leads to early-onset blindness. These mutations result in the destabilization of cGMP phosphodiesterase (PDE), crucial for photoreceptor survival, leading to rapid degeneration of photoreceptors and a lack of electrical responses to light (Ramamurthy2004Leber; Singh2014Early). AIPL1 mutations are also linked to other retinal diseases, such as cone-rod dystrophy and juvenile retinitis pigmentosa, with some C-terminal mutations contributing to these conditions (Ramamurthy2004Leber).

The gene is highly polymorphic, with over 50 mutations identified, complicating the assignment of disease causation. Some mutations cause aberrant pre-mRNA splicing, leading to functionally deficient protein isoforms (Bellingham2015Investigation; SacristanReviriego2020Clinical). Specific variants, such as p.G122R, are associated with milder forms of retinal degeneration, suggesting potential for therapeutic intervention (SacristanReviriego2020Clinical). Gene therapy using adeno-associated viral vectors encoding human AIPL1 has shown potential in rescuing photoreceptor layers in animal models, although rapid degeneration poses challenges for long-term efficacy (Singh2014Early; Tan2012Leber).

## Interactions
AIPL1 interacts with several proteins crucial for photoreceptor function and stability. It acts as a co-chaperone for HSP90, a molecular chaperone, facilitating the stable assembly of the retinal cyclic GMP phosphodiesterase (PDE6) holoenzyme. This interaction is mediated by the FK506-binding protein (FKBP)-like domain and the tetratricopeptide repeat (TPR) domain of AIPL1, which bind to the C-terminal MEEVD motif of HSP90. Mutations in these domains can impair AIPL1's ability to interact with HSP90, affecting PDE6 stability and activity (SacristanReviriego2017The).

AIPL1 also specifically interacts with the farnesylated α subunit of PDE6, a critical interaction for the proper assembly and stability of PDE6. This interaction is essential for preventing the misassembly and degradation of PDE6, highlighting AIPL1's role in posttranslational modification processes (Kolandaivelu2009AIPL1; Majumder2013Interaction).

Additionally, AIPL1 interacts with NUB1, a cell cycle regulator, through its C-terminal region. This interaction is important for the stability and nuclear transport of NUB1, which is involved in protein degradation pathways. Mutations in AIPL1 associated with Leber congenital amaurosis can disrupt this interaction, contributing to photoreceptor degeneration (Akey2002The).


## References


[1. (Akey2002The) D. T. Akey. The inherited blindness associated protein aipl1 interacts with the cell cycle regulator protein nub1. Human Molecular Genetics, 11(22):2723–2733, October 2002. URL: http://dx.doi.org/10.1093/hmg/11.22.2723, doi:10.1093/hmg/11.22.2723. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/11.22.2723)

[2. (Singh2014Early) Ratnesh Kumar Singh, Saravanan Kolandaivelu, and Visvanathan Ramamurthy. Early alteration of retinal neurons inaipl1−/−animals. Investigative Opthalmology &amp; Visual Science, 55(5):3081, May 2014. URL: http://dx.doi.org/10.1167/iovs.13-13728, doi:10.1167/iovs.13-13728. This article has 24 citations.](https://doi.org/10.1167/iovs.13-13728)

[3. (Tan2012Leber) Mei Hong Tan, Donna S. Mackay, Jill Cowing, Hoai Viet Tran, Alexander J. Smith, Genevieve A. Wright, Arundhati Dev-Borman, Robert H. Henderson, Phillip Moradi, Isabelle Russell-Eggitt, Robert E. MacLaren, Anthony G. Robson, Michael E. Cheetham, Dorothy A. Thompson, Andrew R. Webster, Michel Michaelides, Robin R. Ali, and Anthony T. Moore. Leber congenital amaurosis associated with aipl1: challenges in ascribing disease causation, clinical findings, and implications for gene therapy. PLoS ONE, 7(3):e32330, March 2012. URL: http://dx.doi.org/10.1371/journal.pone.0032330, doi:10.1371/journal.pone.0032330. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0032330)

[4. (Kolandaivelu2009AIPL1) Saravanan Kolandaivelu, Jing Huang, James B. Hurley, and Visvanathan Ramamurthy. Aipl1, a protein associated with childhood blindness, interacts with α-subunit of rod phosphodiesterase (pde6) and is essential for its proper assembly. Journal of Biological Chemistry, 284(45):30853–30861, November 2009. URL: http://dx.doi.org/10.1074/jbc.m109.036780, doi:10.1074/jbc.m109.036780. This article has 49 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m109.036780)

[5. (van2002The) J. van der Spuy. The leber congenital amaurosis gene product aipl1 is localized exclusively in rod photoreceptors of the adult human retina. Human Molecular Genetics, 11(7):823–831, April 2002. URL: http://dx.doi.org/10.1093/hmg/11.7.823, doi:10.1093/hmg/11.7.823. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/11.7.823)

[6. (Ramamurthy2004Leber) Visvanathan Ramamurthy, Gregory A. Niemi, Thomas A. Reh, and James B. Hurley. Leber congenital amaurosis linked to aipl1: a mouse model reveals destabilization of cgmp phosphodiesterase. Proceedings of the National Academy of Sciences, 101(38):13897–13902, September 2004. URL: http://dx.doi.org/10.1073/pnas.0404197101, doi:10.1073/pnas.0404197101. This article has 144 citations.](https://doi.org/10.1073/pnas.0404197101)

[7. (Ramamurthy2003AIPL1) Visvanathan Ramamurthy, Melanie Roberts, Focco van den Akker, Gregory Niemi, T. A. Reh, and James B. Hurley. Aipl1, a protein implicated in leber’s congenital amaurosis, interacts with and aids in processing of farnesylated proteins. Proceedings of the National Academy of Sciences, 100(22):12630–12635, October 2003. URL: http://dx.doi.org/10.1073/pnas.2134194100, doi:10.1073/pnas.2134194100. This article has 64 citations.](https://doi.org/10.1073/pnas.2134194100)

[8. (SacristanReviriego2018The) Almudena Sacristan-Reviriego and Jacqueline van der Spuy. The Leber Congenital Amaurosis-Linked Protein AIPL1 and Its Critical Role in Photoreceptors, pages 381–386. Springer International Publishing, 2018. URL: http://dx.doi.org/10.1007/978-3-319-75402-4_47, doi:10.1007/978-3-319-75402-4_47. This article has 9 citations.](https://doi.org/10.1007/978-3-319-75402-4_47)

[9. (Yadav2015Extended) Ravi P Yadav, Anurima Majumder, Lokesh Gakhar, and Nikolai O. Artemyev. Extended conformation of the proline‐rich domain of human aryl hydrocarbon receptor‐interacting protein‐like 1: implications for retina disease. Journal of Neurochemistry, 135(1):165–175, August 2015. URL: http://dx.doi.org/10.1111/jnc.13223, doi:10.1111/jnc.13223. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/jnc.13223)

[10. (Gallon2004Purification) Victoria A. Gallon, Susan E. Wilkie, Evelyne C. Deery, Richard J. Newbold, Melanie M. Sohocki, Shomi S. Bhattacharya, David M. Hunt, and Martin J. Warren. Purification, characterisation and intracellular localisation of aryl hydrocarbon interacting protein-like 1 (aipl1) and effects of mutations associated with inherited retinal dystrophies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1690(2):141–149, October 2004. URL: http://dx.doi.org/10.1016/j.bbadis.2004.06.012, doi:10.1016/j.bbadis.2004.06.012. This article has 7 citations.](https://doi.org/10.1016/j.bbadis.2004.06.012)

[11. (Yadav2017Unique) Ravi P. Yadav, Lokesh Gakhar, Liping Yu, and Nikolai O. Artemyev. Unique structural features of the aipl1–fkbp domain that support prenyl lipid binding and underlie protein malfunction in blindness. Proceedings of the National Academy of Sciences, July 2017. URL: http://dx.doi.org/10.1073/pnas.1704782114, doi:10.1073/pnas.1704782114. This article has 17 citations.](https://doi.org/10.1073/pnas.1704782114)

[12. (SacristanReviriego2017The) Almudena Sacristan-Reviriego, James Bellingham, Chrisostomos Prodromou, Annika N Boehm, Annette Aichem, Neruban Kumaran, James Bainbridge, Michel Michaelides, and Jacqueline van der Spuy. The integrity and organization of the human aipl1 functional domains is critical for its role as a hsp90-dependent co-chaperone for rod pde6. Human Molecular Genetics, 26(22):4465–4480, August 2017. URL: http://dx.doi.org/10.1093/hmg/ddx334, doi:10.1093/hmg/ddx334. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddx334)

[13. (SacristanReviriego2020Clinical) Almudena Sacristan-Reviriego, Hoang Mai Le, Michalis Georgiou, Isabelle Meunier, Beatrice Bocquet, Anne-Françoise Roux, Chrisostomos Prodromou, James Bainbridge, Michel Michaelides, and Jacqueline van der Spuy. Clinical and functional analyses of aipl1 variants reveal mechanisms of pathogenicity linked to different forms of retinal degeneration. Scientific Reports, October 2020. URL: http://dx.doi.org/10.1038/s41598-020-74516-9, doi:10.1038/s41598-020-74516-9. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-74516-9)

[14. (Majumder2013Interaction) Anurima Majumder, Kota N. Gopalakrishna, Pallavi Cheguru, Lokesh Gakhar, and Nikolai O. Artemyev. Interaction of aryl hydrocarbon receptor-interacting protein-like 1 with the farnesyl moiety. Journal of Biological Chemistry, 288(29):21320–21328, July 2013. URL: http://dx.doi.org/10.1074/jbc.M113.476242, doi:10.1074/jbc.m113.476242. This article has 40 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M113.476242)

[15. (Bellingham2015Investigation) James Bellingham, Alice E. Davidson, Jonathan Aboshiha, Francesca Simonelli, James W. Bainbridge, Michel Michaelides, and Jacqueline van der Spuy. Investigation of aberrant splicing induced byaipl1variations as a cause of leber congenital amaurosis. Investigative Opthalmology &amp; Visual Science, 56(13):7784, December 2015. URL: http://dx.doi.org/10.1167/iovs.15-18092, doi:10.1167/iovs.15-18092. This article has 11 citations.](https://doi.org/10.1167/iovs.15-18092)